ACURX PHARMACEUTICALS, INC. ANNOUNCES CLOSING OF $2.5 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

Reuters · 01/07 22:00

Please log in to view news